FRAZER, Pa., Nov. 1 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that Valli F. Baldassano, Esq., has been appointed to the new position of Executive Vice President and Chief Compliance Officer. In this role, Ms. Baldassano reports directly to Chairman and CEO, Frank Baldino Jr., Ph.D., with dotted line reporting to the audit committee of the board of directors.
(Photo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH162 )
"Valli brings a unique perspective on compliance issues as she has represented both corporations in the pharmaceutical industry and the U.S. government," said Frank Baldino, Jr., Ph.D., Chairman and CEO. "We are pleased to have her guide us through this increasingly challenging regulatory environment. Moreover, our decision to make the chief compliance officer position an executive officer of the company underscores the importance of compliance in our organization."
Ms. Baldassano has 21 years experience of legal experience with a strong background in healthcare fraud and compliance issues. Most recently she served as a Partner with Fox Rothschild LLP in Philadelphia where she was a member of the Litigation Department. Her corporate law experience includes eight years in the pharmaceutical industry in senior level compliance positions at Schering-Plough and the former Pharmacia. While at Schering, she negotiated and managed the implementation of two corporate integrity agreements with the Department of Health and Human Services, Office of Inspector General.
Previously, Ms. Baldassano was an Assistant United States Attorney in the Criminal Division of the United States Attorney's Office for the Eastern District of Pennsylvania, where she investigated and tried federal criminal cases involving healthcare fraud and public corruption.
Ms. Baldassano received her Juris Doctor degree from Syracuse
University an
'/>"/>
| SOURCE Cephalon, Inc. Copyright©2007 PR Newswire. All rights reserved |